Our Mission Every day we focus on providing imaginative solutions that make a real difference to patients and physicians. Focus on Innovation With relentless curiosity we work with clinicians to find elegant new ways to transform patient care. There are no limits to where our ideas will take us. About BTG The key to our success is the quality of our people and our strong foundation of core company values.
A Retrospective Study of Medicare claim data shows patients treated with Voraxaze® had shorter hospitalizations and lower mortality BTG announces National Reimbursement for TheraSphere® in France Arizona Patients Successfully Receive the World’s First Bioconvertible IVC Filter Commercially Offer 2018 Annual General Meeting Recommended Cash Offer for BTG plc by Boston Scientific Corporation Latest Share Price Current 834.50 Change +1.00 +0.12% LSE:BTG PLC 15 MIN DELAY Detailed share price data "We are building a strong reputation among leading specialist physicians for both the quality of our products and our commitment to innovation and clinical development." LOUISE MAKIN CHIEF EXECUTIVE OFFICER TOGETHER WE’RE BETTER REACHING FURTHER WITH INTERVENTIONAL MEDICINE INVESTORS We’re committed to an open dialogue with current and potential investors to share our strategy and our progress. CAREERS BTG’s success stems from the hard work and significant contributions of our people. LATEST UPDATES: BTG Corporate LATEST UPDATES: BTG Interventional Oncology LATEST UPDATES: BTG Interventional Pumonology LATEST UPDATES: BTG Vascular LATEST UPDATES: BTG Pharmaceuticals Select a news stream BTG Corporate BTG Interventional Oncology BTG Interventional Pumonology BTG Vascular BTG Pharmaceuticals Follow this stream: Follow this stream: Follow this stream: Follow this stream: Follow this stream: BTG A Retrospective Study of Medicare claim data shows patients treated with Voraxaze® had shorter hospitalizations and… https://t.co/4tP6lvUsIu @BTG International - Digital Innovation at BTG BTG Minister for Public Health @BrineMinister shows support for Kidney Cancer Awareness Week #KCAW2019 https://t.co/brhjozM33z BTG Big congratulations to all our BTG #InterventionalOncology EMEA 2018 Award Winners! 🏆"If it can be done, we'll do i… https://t.co/ozAm8NhjN8 BTG Here is a take by Dr. David Hahn of @BTG on digital and healthcare, including clinical trials, and our leadership t… https://t.co/DheANGzHMp BTG 🇪🇸 Building our patient focused team project using 16,384 lego blocks! Each block could represent at least one pati… https://t.co/trnQOIoxqs BTGIO 🇺🇸We're busy getting ready for #SIR19ATX ! First up is our dedicated BTG@SIR microsite - browse our packed program… https://t.co/H7WiflFo3Z @BTG International - Digital Innovation at BTG BTGIO 🇺🇸We're busy getting ready for #SIR19ATX ! First up is our dedicated BTG@SIR microsite - browse our packed program… https://t.co/H7WiflFo3Z BTGIO #SIR19ATX coming so soon! Im pleased to announce the third installment of the #twittIR meetup generously supported… https://t.co/ZBJwnNTBrB BTGIO #SIR19ATX coming so soon! Im pleased to announce the third installment of the #twittIR meetup generously supported… https://t.co/ZBJwnNTBrB BTGIO 🇺🇸“Simplicit90Y allows physicians to personalize the dose of #Y90 therapies, such as TheraSphere, to suit each of t… https://t.co/VZfohTkZ39 BTGIO 🇺🇸We're busy getting ready for #SIR19ATX ! First up is our dedicated BTG@SIR microsite - browse our packed program… https://t.co/H7WiflFo3Z @BTG International - Digital Innovation at BTG BTGIO #SIR19ATX coming so soon! Im pleased to announce the third installment of the #twittIR meetup generously supported… https://t.co/ZBJwnNTBrB BTGIO 🇺🇸“Simplicit90Y allows physicians to personalize the dose of #Y90 therapies, such as TheraSphere, to suit each of t… https://t.co/VZfohTkZ39 BTGIO 🇬🇧Seeing the amazing effects of ICE during our cool #cryoablation hands-on training in Camberley today! ❄️… https://t.co/aiesbpjXRg BTGIO Greater than 4cm? Anterior location? Next to bowel? No problem for interventional radiology (#IRad) Using position… https://t.co/k0CWaupJlk BTGVascular Thanks for making this another successful #AVF! To learn more about treating GSV incompetence with #Varithena, visi… https://t.co/JOknnzkjwM @BTG Vascular - CU 4.0 In-Service - Full Sequence In-Service video @BTG Vascular - CU 4.0 In-Service - Troubleshooting the Control Unit @BTG Vascular - CU 4.0 In-Service - Control Unit 4 0 Set up and Operation @BTG Vascular - CU 4.0 In-Service - Post treatment follow up @BTG Vascular - CU 4.0 In-Service - Infusion Set up and Device Securement BTGPharma As snakebite season approaches, get to know some of the snakes that are slithering around the nation. You can disco… https://t.co/t8VROzbDZE @BTG International - Digital Innovation at BTG BTGPharma A Retrospective Study of Medicare claim data shows patients treated with Voraxaze® had shorter hospitalizations and… https://t.co/4tP6lvUsIu BTGPharma Did you know: The Tarheel State leads the nation in venomous snakebites. Which serpents are slithering in your stat… https://t.co/ifJlZt9Q3d BTGPharma Snakebites for inservice • Pit vipers = local swelling/pain, thrombocytopenia - Mojave Rattlesnake = paralysi… https://t.co/g6q3DCtvAh BTGPharma As the weather warms, groundhogs aren’t the only creatures coming out of hiding. Snakes will be crawling around to… https://t.co/Ck07ar1jkJ
"We are building a strong reputation among leading specialist physicians for both the quality of our products and our commitment to innovation and clinical development." LOUISE MAKIN CHIEF EXECUTIVE OFFICER
REACHING FURTHER WITH INTERVENTIONAL MEDICINE INVESTORS We’re committed to an open dialogue with current and potential investors to share our strategy and our progress. CAREERS BTG’s success stems from the hard work and significant contributions of our people.